Chris Hobson, MD, Orion Health, speaks with Drew Ivan, Lyniate, and Matthew Michela, Life Image, who discuss the current state of interoperability, how organizations are balancing COVID response in order to comply with ONC and CMS rules, and...
Chris Hobson, MD, Orion Health, speaks with Drew Ivan, Lyniate, and Matthew Michela, Life Image, who discuss the current state of interoperability, how organizations are balancing COVID response in order to comply with ONC and CMS rules, and...
Joel Diamond, MD, chief medical officer, 2bPrecise, discusses the overall benefits of utilizing precision medicine in practice, and highlights how the use of genetic testing and precision medicine can help prevent and prepare the health care...
Joel Diamond, MD, chief medical officer, 2bPrecise, discusses the overall benefits of utilizing precision medicine in practice, and highlights how the use of genetic testing and precision medicine can help prevent and prepare the health care...
Eric Sullivan, senior vice president of innovation and data strategies, Inovalon, discusses the Consumer Health Gateway, a new portal that allows health plans to build their own Patient Access API to comply with the new requirement of the...
Eric Sullivan, senior vice president of innovation and data strategies, Inovalon, discusses the Consumer Health Gateway, a new portal that allows health plans to build their own Patient Access API to comply with the new requirement of the...
Matthew Michela, CEO, Life Image, and Sandra Lillie, director of enterprise imaging sales, Hyland Health, detail how providers should think about managing their clinical content to improve the patient experience, and also highlight the...
Matthew Michela, CEO, Life Image, and Sandra Lillie, director of enterprise imaging sales, Hyland Health, detail how providers should think about managing their clinical content to improve the patient experience, and also highlight the...
Erin Jospe, MD, discusses why hospitals will need to offer a hybrid, flexible model that blends virtual and traditional care in order to remain competitive.
Erin Jospe, MD, discusses why hospitals will need to offer a hybrid, flexible model that blends virtual and traditional care in order to remain competitive.
Angela Nicholas, MD, the chief medical officer, Einstein Medical Center Montgomery, discusses how telehealth and at-home screening tests can help health care providers and patients prioritize early detection while navigating this new normal.
Angela Nicholas, MD, the chief medical officer, Einstein Medical Center Montgomery, discusses how telehealth and at-home screening tests can help health care providers and patients prioritize early detection while navigating this new normal.
Benjamin Levy, MD, division head of gastroenterology, Mount Sinai, discusses the backlog of screenings many health systems are facing, provides tips for health care providers, and highlights the benefits of at-home testing.
Benjamin Levy, MD, division head of gastroenterology, Mount Sinai, discusses the backlog of screenings many health systems are facing, provides tips for health care providers, and highlights the benefits of at-home testing.
Art Papier, MD, CEO, VisualDX, outlines how telemedicine and technology use can help health care workers on the frontlines, and provides tips for patients and providers to assist them with getting the most out of telemedicine appointments.
Art Papier, MD, CEO, VisualDX, outlines how telemedicine and technology use can help health care workers on the frontlines, and provides tips for patients and providers to assist them with getting the most out of telemedicine appointments.
Oliver Lignell, vice president of Virtual Health, Avia, discusses how hospitals systems are currently leveraging digital data, and offers tips to help utilize the digital landscape during this pandemic.
Oliver Lignell, vice president of Virtual Health, Avia, discusses how hospitals systems are currently leveraging digital data, and offers tips to help utilize the digital landscape during this pandemic.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...